For the third consecutive year, Molecular Cancer is excited to announce a new thematic series covering the general research area of Non-coding RNAs and RNA modifiers in cancer progression and cancer cells resistance to therapies. Of particular focus are original research papers reporting data from clinical trials or animal models. In addition to original research articles, we aim to publish letters to the Editor and comprehensive reviews.
All submitted manuscripts will undergo rigorous initial evaluation within 7 days, and then, when appropriate, will be sent out for external peer review to assess the suitability for publication. Submit here.
Submission deadline: December 15th, 2019
Expected publication date: February 2020
